Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.

David Manz, a PNNL cybersecurity scientist working to build more resilient architectures for the nation’s critical infrastructure, was inducted to the National Science Foundation’s CyberCorps: Scholarship for Service (SFS) Hall of Fame.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

In a special edition of the Journal of Information Warfare, Pacific Northwest National Laboratory researchers explore the revolution of technologies defending the nation’s critical infrastructure.

PNNL and the 13 other national laboratories of the Grid Modernization Laboratory Consortium (GMLC) will be sharing their R&D work and technologies for grid modernization at DistribuTECH International in San Antonio Jan. 28-30.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

PNNL will lead three new grid modernization projects funded by the Department of Energy. The projects focus on scalability and usability, networked microgrids, and machine learning for a more resilient, flexible and secure power grid.

Seventeen teams from regional colleges and universities gathered at PNNL Nov. 16 to put their cyber skills to the test by protecting critical energy infrastructure against simulated cyberattacks as part of DOE's CyberForce Competition.

Congratulations to Lori Ross O’Neil (NSD) for being named the IEEE Richland Section Women in Engineering (WIE) Engineer of the Year 2019.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

Three powerhouses in the realm of artificial intelligence have become partners in a new research center created by the U.S. Department of Energy.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

He is being recognized for his contributions involving various kinds of separations with mass spectrometry (MS).